[Facial palsy associated with leptospirosis].
Lahsen
A Oulad
AO
Rachidi
T
T
Sodqi
M
M
Abada
R
R
Marhoum
K Elfilali
KE
D000293:Adolescent; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D004199:Disease Vectors; D004359:Drug Therapy, Combination; D005158:Facial Paralysis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D041383:Leptospira interrogans serovar icterohaemorrhagiae / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D008297:Male; D009018:Morocco; D010406:Penicillins / Q000627:therapeutic use; D017713:Platelet Transfusion; D011239:Prednisolone / Q000627:therapeutic use; D011329:Prisoners; D051381:Rats / Q000382:microbiology; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy; D014396:Tuberculosis, Pleural / Q000150:complications; D014895:Weil Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D000907:Antibodies, Bacterial; D007075:Immunoglobulin M; D010406:Penicillins; D011239:Prednisolone